Researcher.Life Logo

ACS Chemical Neuroscience : Impact Factor & More

eISSN: 1948-7193pISSN: 1948-7193

Aims and Scope of ACS Chemical Neuroscience

ACS Chemical Neuroscience is a peer-reviewed scientific journal published by the American Chemical Society. It covers research on the molecular underpinnings of nerve function in organisms and animal models. The journal was established in January 2010. The journal is one of the first journals of the American Chemical Society to be available in online-only format. The founding editor-in-chief is Craig W. Lindsley (Vanderbilt University). Less

Key Metrics

CiteScore
7.7
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SJR
Q2Physiology
SNIP
1.08
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ACS Chemical Neuroscience

ACS Chemical Neuroscience Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER CHEMICAL SOC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ACS Chemical Neuroscience ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ACS Chemical Neuroscience

Gut Microbiota Dysbiosis Drives Early Alzheimer's Pathogenesis via Microglial TREM2/SYK/NF-κB Signaling Axis.
  • 14 May 2026
  • ACS chemical neuroscience
Advances in Real-Time Electrochemical Monitoring of Neurotransmitter Dynamics in Drosophila.
  • 13 May 2026
  • ACS chemical neuroscience
Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation.
  • 8 May 2026
  • ACS chemical neuroscience
A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of Tau.
  • 8 May 2026
  • ACS chemical neuroscience
Profiling Endogenous Opioid Peptide Release from Adrenal Chromaffin Cells.
  • 6 May 2026
  • ACS chemical neuroscience
Synthesis of Clausenamide Isomers and Evaluation of Their Potential as Cortical Neuroplastogens.
  • 6 May 2026
  • ACS chemical neuroscience
Gut Microbiota Dysbiosis Drives Early Alzheimer's Pathogenesis via Microglial TREM2/SYK/NF-κB Signaling Axis.
  • 14 May 2026
  • ACS chemical neuroscience
Advances in Real-Time Electrochemical Monitoring of Neurotransmitter Dynamics in Drosophila.
  • 13 May 2026
  • ACS chemical neuroscience
Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation.
  • 8 May 2026
  • ACS chemical neuroscience
A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of Tau.
  • 8 May 2026
  • ACS chemical neuroscience
Profiling Endogenous Opioid Peptide Release from Adrenal Chromaffin Cells.
  • 6 May 2026
  • ACS chemical neuroscience
Synthesis of Clausenamide Isomers and Evaluation of Their Potential as Cortical Neuroplastogens.
  • 6 May 2026
  • ACS chemical neuroscience

FAQs on ACS Chemical Neuroscience